Mankind Pharma Adopts AI Across Its Value Chain

Mankind Pharma, India’s fourth-largest pharmaceutical company, has announced a strategic collaboration with OpenAI to embed advanced artificial intelligence across its operations. By deploying OpenAI Enterprise and ChatGPT Enterprise, Mankind aims to enhance innovation, efficiency, and value delivery across every stage of its value chain—from research and development (R&D) to marketing and customer engagement. This initiative marks a major step forward for the Indian pharmaceutical sector, setting new benchmarks in the use of AI for regulated industries.

Mankind Pharma’s AI-Driven Transformation

Mankind Pharma is one of the first Indian pharmaceutical companies to fully integrate AI across its core operations and business functions. With this move, the company seeks to strengthen its competitive edge in a rapidly evolving healthcare ecosystem, where data-driven insights, compliance, and efficiency are mission-critical.

The partnership will enable Mankind to utilize OpenAI’s GPT-5 and other advanced AI models to streamline discovery, development, and delivery of healthcare solutions.

Areas of AI Integration

Mankind Pharma will deploy OpenAI Enterprise solutions across a wide range of business functions:

• Field Force Enablement: AI will provide real-time insights, multilingual communication support, and performance tracking to improve productivity.

• Digital Marketing: Smarter messaging, content creation, and faster campaign rollouts tailored to specific customer segments.

• Research & Development: Accelerating drug discovery and clinical research by turning vast datasets into actionable insights.

• Manufacturing: Enhancing process reliability, predictive maintenance, and quality assurance.

• Medical Affairs: Streamlining compliance, communication with healthcare professionals, and delivering accurate medical information efficiently.

Empowering Teams with ChatGPT Enterprise

Internally, Mankind Pharma has rolled out ChatGPT Enterprise to empower teams with AI-powered tools. These include customised GPTs that allow employees to design AI assistants tailored to their workflows.

Custom GPTs enable:

• Industry-specific knowledge integration

• Proprietary data inclusion for better decision-making

• Personalised AI personalities and tones for communication

• Workflow automation without complex coding requirements

This level of customisation is helping teams build targeted AI solutions that directly support their everyday roles.

Leadership Vision

Arjun Juneja, Chief Operating Officer of Mankind Pharma, emphasized the transformative impact of this collaboration:

“At Mankind Pharma, we see working with OpenAI as a pivotal step in building the pharma organisation of the future. By integrating advanced AI into our core operations, we’re enabling our teams to move faster, work smarter, and unlock insights that drive real-world impact. This is not just about automation; it’s about creating a responsive, intelligent, and future-ready enterprise.”

His remarks highlight how AI is being used not only for efficiency but also for value creation and innovation.

Real-World Impact Since Deployment

Since July 2025, Mankind Pharma has been actively deploying customised GPTs across its workforce. The measurable benefits include:

• Sales & Marketing: Stronger messaging, multilingual communication, and improved campaign performance.

• Commercial Operations: Better demand planning and procurement processes.

• Clinical Insights: Faster, more reliable decision-making for R&D.

• Manufacturing: Improved accuracy, predictive insights, and streamlined production processes.

• Leadership Focus: With AI automating operational workflows, leadership can concentrate on growth and strategy.

OpenAI’s Perspective

Commenting on the partnership, Oliver Jay, Managing Director, International at OpenAI, stated:

“Mankind Pharma’s company-wide adoption of ChatGPT Enterprise shows the practical role AI can play in regulated industries such as pharmaceuticals. By integrating AI into research, operations, and medical communications, Mankind is taking meaningful steps to improve efficiency and support innovation.”

This reflects the responsible and safe application of AI within a highly regulated sector.

A New Benchmark in Indian Pharma

Mankind Pharma’s decision to integrate AI at scale signals a paradigm shift for the Indian pharmaceutical industry. By leveraging OpenAI’s advanced technologies, the company is not only improving operational excellence but also positioning itself as a pioneer in applying AI responsibly in healthcare.